Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2025-12-25 @ 9:59 PM
Study NCT ID:
NCT05794958
Status:
RECRUITING
Last Update Posted:
2025-09-23
First Post:
2023-03-20
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Evaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-Cel
Sponsor:
Stanford University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-23
Start Date Type:
ACTUAL
Primary Completion Date:
2038-04-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2038-04-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-20
First Submit QC Date:
None
Study First Post Date:
2023-04-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-22
Last Update Post Date:
2025-09-23
Last Update Post Date Type:
ESTIMATED